ARCHIVES

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says

November 27, 1981

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Ontak Approved For Lymphoma

October 31, 2008

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Concepts Approved For $26.5Million In DCPC contracts, Including Heavy Smoker Program

February 1, 1985